Stock Track | GE Healthcare Pre-market Soars 5.76% as Q2 Earnings Beat and Full-Year Guidance Reaffirmed

Stock Track
07/29

GE Healthcare Technologies Inc (GEHC) stock surged 5.76% in pre-market trading on Wednesday, driven by stronger-than-expected second-quarter results and a reaffirmed full-year outlook.

The company reported Q2 revenue of $5.3 billion, surpassing the IBES estimate of $5.264 billion, while adjusted earnings per share reached $1.13, well above the $1.04 consensus. Net income for the quarter was $561 million, with EPS of $1.24. The robust performance signals healthy demand across its imaging, ultrasound, and patient care segments.

Investors also welcomed the reaffirmation of 2026 guidance, with adjusted EPS projected between $4.80 and $5.00, aligning with the FactSet estimate of $4.88. This vote of confidence carries added weight after the company had trimmed its forecast in April due to cost headwinds, making the steady outlook a positive catalyst for the stock.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10